Mitsubishi Tanabe Pharma Corp - Strategic SWOT Analysis Review

July 2021 | 46 pages | ID: M2E77F7B0682EN
GlobalData

Abstracts

Mitsubishi Tanabe Pharma Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – GlobalData’s summarization of the company’s business strategy.
• SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.

Highlights

Mitsubishi Tanabe Pharma Corp (Mitsubishi Tanabe), a subsidiary of Mitsubishi Chemical Holdings Corp, identifies, develops, manufactures, procures and commercializes ethical drugs and over-the-counter (OTC) pharmaceutical products. The company develops ethical drugs for autoimmune disease, diabetes, kidney diseases, central nervous system (CNS) disorders, and others. It also develops vaccines for preventing various infectious diseases. Mitsubishi Tanabe also offers major products for skin conditions and digestive medicines. The company markets its products to wholesalers, hospitals, clinics, and drugstores. It has subsidiaries in Asia, Europe, and North America. Mitsubishi Tanabe is headquartered in Osaka, Japan.

Mitsubishi Tanabe Pharma Corp Key Recent Developments

May 25,2021: Establishment of AI Technologies for drug screening to accelerate data-driven drug discovery
Mar 31,2021: The Global Health Innovative Technology Fund provides grant to Mitsubishi Tanabe Pharma and DNDi for Chagas disease and leishmaniasis drug discovery
Mar 17,2021: Mitsubishi Tanabe Pharma America presents data on impact of ALS Symptoms on patients' ability to independently conduct daily activities
Mar 03,2021: Mitsubishi Tanabe Pharma: Establish NeuroDiscovery Lab in the Boston area to strengthen the discovery of drug targets for the Central Nervous System Disorders
Mar 03,2021: Mitsubishi Tanabe Pharma: Formulation of MISSION, VISION 30 and Medium-Term Management Plan 21–25 -Creating hope for all facing illness

Reasons to Buy

• Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
• Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
• Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
• Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

Contents

SECTION 1 - ABOUT THE COMPANY

Mitsubishi Tanabe Pharma Corp - Key Facts
Mitsubishi Tanabe Pharma Corp - Key Employees
Mitsubishi Tanabe Pharma Corp - Major Products and Services
Mitsubishi Tanabe Pharma Corp - History
Mitsubishi Tanabe Pharma Corp - Company Statement
Mitsubishi Tanabe Pharma Corp - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture

SECTION 2 – COMPANY ANALYSIS

Company Overview
Mitsubishi Tanabe Pharma Corp - Business Description
Product Category: Domestic Ethical Drugs
Performance
Product Category: Overseas Ethical Drugs
Performance
Product Category: Royalty Revenue, etc.
Performance
Geographical Segment: Domestic
Performance
Geographical Segment: Overseas
Performance
R&D Overview
Mitsubishi Tanabe Pharma Corp - SWOT Analysis
SWOT Analysis - Overview
Mitsubishi Tanabe Pharma Corp - Strengths
Mitsubishi Tanabe Pharma Corp - Weaknesses
Mitsubishi Tanabe Pharma Corp - Opportunities
Mitsubishi Tanabe Pharma Corp - Threats
Mitsubishi Tanabe Pharma Corp - Key Competitors

SECTION 3 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Mitsubishi Tanabe Pharma Corp, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Mitsubishi Tanabe Pharma Corp, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Mitsubishi Tanabe Pharma Corp, Recent Deals Summary

SECTION 4 – COMPANY’S RECENT DEVELOPMENTS

May 25, 2021: Establishment of AI Technologies for drug screening to accelerate data-driven drug discovery
Mar 31, 2021: The Global Health Innovative Technology Fund provides grant to Mitsubishi Tanabe Pharma and DNDi for Chagas disease and leishmaniasis drug discovery
Mar 17, 2021: Mitsubishi Tanabe Pharma America presents data on impact of ALS Symptoms on patients' ability to independently conduct daily activities
Mar 03, 2021: Mitsubishi Tanabe Pharma: Establish NeuroDiscovery Lab in the Boston area to strengthen the discovery of drug targets for the Central Nervous System Disorders
Mar 03, 2021: Mitsubishi Tanabe Pharma: Formulation of MISSION, VISION 30 and Medium-Term Management Plan 21–25 -Creating hope for all facing illness
Mar 03, 2021: Mitsubishi Tanabe Pharma America announces establishment of NeuroDiscovery Lab Research Base in Cambridge, Mass
Feb 03, 2021: Mitsubishi Tanabe Pharma: Financial results for the 3rd Quarter of FY2020 ending March 31, 2021 and Forecasts for FY2020
Jan 18, 2021: Mitsubishi Tanabe Pharma and TAKEDA share internal experimental data to accelerate data-driven drug discovery
Jan 14, 2021: Notice of the Arbitral Award on the license agreement with Kolon Life Science
Aug 18, 2020: Zosano Pharma announces agreement to collaborate with Mitsubishi Tanabe Pharma

SECTION 5 – APPENDIX

Methodology
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

Mitsubishi Tanabe Pharma Corp, Key Facts
Mitsubishi Tanabe Pharma Corp, Key Employees
Mitsubishi Tanabe Pharma Corp, Major Products and Services
Mitsubishi Tanabe Pharma Corp, History
Mitsubishi Tanabe Pharma Corp, Other Locations
Mitsubishi Tanabe Pharma Corp, Subsidiaries
Mitsubishi Tanabe Pharma Corp, Joint Venture
Mitsubishi Tanabe Pharma Corp, Key Competitors
Mitsubishi Tanabe Pharma Corp, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Mitsubishi Tanabe Pharma Corp, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Mitsubishi Tanabe Pharma Corp, Recent Deals Summary

List Of Figures

LIST OF FIGURES

Mitsubishi Tanabe Pharma Corp, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Mitsubishi Tanabe Pharma Corp, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021